Market By Type, Substrate Material, End User And Geography | Forecasts 2019-2027
Triton Market Research has concluded that the Middle East & Africa biochips market is projected to grow at a CAGR of 14.41% in the estimated years 2019-2027.
A biochip is a type of microchip. It consists of microarrays mounted on a solid substrate that allow several biochemical reactions to be performed at the simultaneously in order to achieve higher throughput and speed.
The biochips report on the Middle East & Africa region includes the countries:
O South Africa
O Turkey
O The UAE
O Saudi Arabia
O Rest of the Middle East & Africa
We provide additional customization based on your specific requirements. Request For Customization
The signing of the MoU for the purpose of developing the pharmaceutical sector by attracting fundings from multinational pharmaceutical companies, along with the key biotechnological research and development investments are expected to boost the R&D in biochip technology for cost-effective drug development in the biochip market in the Middle East & Africa.
Several major international and regional pharmaceutical companies are looking to set their base in the UAE as a potential market. The government in Turkey has undertaken strategic economic development plans that aim for a pharmaceutical industry which mostly produces and exports high value biotechnology products.
A detailed analysis of the market attractiveness index, key market strategies, industry player positioning, regulatory framework, industry components, market opportunity insights, key insights, key impact analysis, Porter’s five force analysis, market definition, vendor scorecard has been provided in the report.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST & AFRICA BIOCHIPS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.3. EVOLUTION
& TRANSITION OF BIOCHIPS
2.4. PORTER'S
FIVE FORCE ANALYSIS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
IMPACT ANALYSIS
2.10.
MARKET OPPORTUNITY INSIGHTS
2.11.
INDUSTRY PLAYER POSITIONING
2.12.
KEY MARKET STRATEGIES
2.13.
MARKET DRIVERS
2.13.1.
GROWTH IN PERSONALIZED
MEDICINES
2.13.2.
RISING INCIDENCES &
TREATMENT OF CANCER
2.13.3.
CONSTANT RISE IN HEALTHCARE
SPENDING WORLDWIDE
2.13.4.
INCREASING NUMBER OF
INVESTMENTS IN BIOTECHNOLOGY R&D
2.14.
MARKET RESTRAINTS
2.14.1.
INEQUALITIES IN HEALTHCARE
ACCESS
2.14.2.
INADEQUATE TECHNICAL AWARENESS
RELATED TO BIOCHIPS
2.14.3.
COMPLEXITY OF BIOLOGICAL
SYSTEMS
2.15.
MARKET OPPORTUNITIES
2.15.1.
DEVELOPMENTS IN BIOCHIPS
TECHNOLOGY
2.15.2.
ASIA PACIFIC TO OFFER
LUCRATIVE GROWTH OPPORTUNITIES
2.15.3.
WIDENING APPLICATION AREAS OF
BIOCHIPS
2.16.
MARKET CHALLENGES
2.16.1.
AVAILABILITY OF SUBSTITUTE
TECHNOLOGIES
2.16.2.
UNCLEAR REGULATORY GUIDELINES
2.16.3.
COST CONSTRAINTS
3. MIDDLE
EAST & AFRICA BIOCHIPS MARKET OUTLOOK - BY TYPE
3.1. DNA
CHIPS
3.1.1. AGRICULTURAL
BIOTECHNOLOGY
3.1.2. CANCER
DIAGNOSTICS & TREATMENT
3.1.3. DRUG
DISCOVERY
3.1.4. GENE
EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE
NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER
DNA CHIPS
3.2. LAB
ON A CHIP
3.2.1. CLINICAL
DIAGNOSTICS
3.2.2. DRUG
DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT
OF CARE & IN VITRO DIAGNOSIS
3.2.5. PROTEOMICS
3.2.6. OTHER
LAB ON A CHIP
3.3. PROTEIN
CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG
DISCOVERY
3.3.3. EXPRESSION
PROFILING
3.3.4. HIGH
THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER
PROTEIN CHIPS
3.4. OTHER
CHIPS
3.4.1. CELL
ARRAYS
3.4.2. TISSUE
ARRAYS
4. MIDDLE
EAST & AFRICA BIOCHIPS MARKET OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER
SUBSTRATE MATERIALS
5. MIDDLE
EAST & AFRICA BIOCHIPS MARKET OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY
AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS
AND DIAGNOSTICS CENTERS
5.3. ACADEMIC
AND RESEARCH INSTITUTE
6. MIDDLE
EAST & AFRICA BIOCHIPS MARKET - REGIONAL OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.2. TURKEY
6.3. SAUDI
ARABIA
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. AGILENT
TECHNOLOGY INC.
7.2. BIOCHAIN
INSTITUTE INC.
7.3. BIOMERIEUX
SA
7.4. BIO-RAD
LABORATORIES INC.
7.5. CEPHEID
INC.
7.6. CYBRDI
INC.
7.7. FLUIDIGM
CORPORATION
7.8. GAMIDA
FOR LIFE GROUP
7.9. ILLUMINA
INC.
7.10.
IMGENEX
7.11.
MERCK GMBH
7.12.
ORIGENE TECHNOLOGIES INC.
7.13.
PERKINELMER INC.
7.14.
SAMSUNG ELECTRONICS INC.
7.15.
THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1. MARKET
ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET
TABLE 2. VENDOR
SCORECARD OF BIOCHIPS MARKET
TABLE 3. REGULATORY FRAMEWORK
OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC
DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. NOTABLE
INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
TABLE 6. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 7. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 8. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 9. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 10. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
FIGURE 1. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 2. PORTER’S FIVE
FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT
ANALYSIS
FIGURE 4. TIMELINE OF
BIOCHIPS
FIGURE 5. MARKET
OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 6. MARKET
OPPORTUNITY INSIGHTS, BY END USER, 2018
FIGURE 7. INDUSTRY
COMPONENTS OF BIOCHIPS MARKET
FIGURE 8. KEY PLAYERS
POSITIONING IN 2018 (%)
FIGURE 9. WORLDWIDE
HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
FIGURE 10. COMPARISON
OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE
FIGURE 11. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 12. MIDDLE EAST
& AFRICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $
MILLION)
FIGURE 13. MIDDLE EAST
& AFRICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027
(IN $ MILLION)
FIGURE 14. MIDDLE EAST
& AFRICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 15. MIDDLE EAST
& AFRICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
FIGURE 16. MIDDLE EAST
& AFRICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 17. MIDDLE EAST &
AFRICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING,
2019-2027 (IN $ MILLION)
FIGURE 18. MIDDLE EAST
& AFRICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 19. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 20. MIDDLE EAST
& AFRICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $
MILLION)
FIGURE 21. MIDDLE EAST
& AFRICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 22. MIDDLE EAST &
AFRICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 23. MIDDLE EAST
& AFRICA LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS,
2019-2027 (IN $ MILLION)
FIGURE 24. MIDDLE EAST
& AFRICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 25. MIDDLE EAST
& AFRICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $
MILLION)
FIGURE 26. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 27. MIDDLE EAST
& AFRICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 28. MIDDLE EAST
& AFRICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 29. MIDDLE EAST
& AFRICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 30. MIDDLE EAST
& AFRICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN
$ MILLION)
FIGURE 31. MIDDLE EAST
& AFRICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 32. MIDDLE EAST
& AFRICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $
MILLION)
FIGURE 33. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 34. MIDDLE EAST
& AFRICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 35. MIDDLE EAST
& AFRICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 36. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
FIGURE 37. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 38. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 39. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $
MILLIONS)
FIGURE 40. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES,
2019-2027 (IN $ MILLIONS)
FIGURE 41. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027
(IN $ MILLIONS)
FIGURE 42. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN
$ MILLIONS)
FIGURE 43. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 44. UNITED ARAB
EMIRATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 45. SAUDI ARABIA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 46. TURKEY
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 47. SOUTH AFRICA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 48. REST OF
MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)